Cargando…

Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma

SIMPLE SUMMARY: Proton beam therapy (PBT) has the potential to improve local tumor control and subsequently improve survival of patients with inoperable or recurrent intrahepatic cholangiocarcinoma (IHCC); however, studies on PBT in patients with IHCC are still limited. This study evaluated the effi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Tae Hyun, Woo, Sang Myung, Lee, Woo Jin, Chun, Jung Won, Cho, Yu Ri, Kim, Bo Hyun, Koh, Young-Hwan, Kim, Sang Soo, Oh, Eun Sang, Lee, Do Yeul, Lee, Sung Uk, Suh, Yang-Gun, Moon, Sung Ho, Park, Joong-Won
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688899/ https://www.ncbi.nlm.nih.gov/pubmed/36428654 http://dx.doi.org/10.3390/cancers14225561

Ejemplares similares

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Proton Beam Therapy for Treatment-Naïve Hepatocellular Carcinoma and Prognostic Significance of Albumin-Bilirubin (ALBI) Grade
por: Kim, Tae Hyun, et al.
Publicado: (2022)

Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2017)

Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma
por: Kim, Young-Il, et al.
Publicado: (2013)

Postoperative CA19-9 Change Is a Useful Predictor of Intrahepatic Cholangiocarcinoma Survival following Liver Resection
por: Yoo, Tae, et al.
Publicado: (2015)

Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma?
por: Kim, Tae Hyun, et al.
Publicado: (2019)

Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation
por: Ha, Boram, et al.
Publicado: (2019)

Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2015)

Effectiveness and Safety of Simultaneous Integrated Boost-Proton Beam Therapy for Localized Pancreatic Cancer
por: Kim, Tae Hyun, et al.
Publicado: (2018)

Reduced levels of N’-methyl-2-pyridone-5-carboxamide and lysophosphatidylcholine 16:0 in the serum of patients with intrahepatic cholangiocarcinoma, and the correlation with recurrence-free survival
por: Kim, Kyung-Hee, et al.
Publicado: (2017)

A Comparative Analysis of Photon versus Proton Beam Therapy in Neoadjuvant Concurrent Chemoradiotherapy for Intrathoracic Squamous Cell Carcinoma of the Esophagus at a Single Institute
por: Choi, Jin-Ho, et al.
Publicado: (2022)

Efficacy and feasibility of proton beam radiotherapy using the simultaneous integrated boost technique for locally advanced pancreatic cancer
por: Kim, Tae Hyun, et al.
Publicado: (2020)

Detection of distant metastasis to skeletal muscle by (18)F-FDG-PET in a case of intrahepatic cholangiocarcinoma
por: Park, Se Kyung, et al.
Publicado: (2010)

Effect of age on the prognosis of intrahepatic cholangiocarcinoma
por: Kim, Jung Hun, et al.
Publicado: (2023)

Novel Preoperative Nomogram for Prediction of Futile Resection in Patients Undergoing Exploration for Potentially Resectable Intrahepatic Cholangiocarcinoma
por: Nam, Kwangwoo, et al.
Publicado: (2017)

High platelet-to-lymphocyte ratio is associated with poor prognosis in patients with unresectable intrahepatic cholangiocarcinoma receiving gemcitabine plus cisplatin
por: Huh, Gunn, et al.
Publicado: (2020)

Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
por: Kim, Yeon-Joo, et al.
Publicado: (2013)

Exophytic combined hepatocellular carcinoma and cholangiocarcinoma
por: Noh, Sang Jae, et al.
Publicado: (2012)

Photon Versus Proton Beam Therapy for T1–3 Squamous Cell Carcinoma of the Thoracic Esophagus Without Lymph Node Metastasis
por: Suh, Yang-Gun, et al.
Publicado: (2021)

ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma
por: Park, Kyun Woo, et al.
Publicado: (2013)

Patterns of Proton Beam Therapy Use in Clinical Practice between 2007 and 2019 in Korea
por: Lee, Sung Uk, et al.
Publicado: (2021)

Proximal Resection Margins: More Prognostic than Distal Resection Margins in Patients Undergoing Hilar Cholangiocarcinoma Resection
por: Yoo, Tae, et al.
Publicado: (2018)

Genetic features associated with (18)F-FDG uptake in intrahepatic cholangiocarcinoma
por: Ahn, Keun Soo, et al.
Publicado: (2019)

Pharmacological Inhibition of Sonic Hedgehog Signaling Suppresses Tumor Development in a Murine Model of Intrahepatic Cholangiocarcinoma
por: Cho, Kyungjoo, et al.
Publicado: (2021)

A Case of Clonorchiasis with Focal Intrahepatic Duct Dilatation Mimicking an Intrahepatic Cholangiocarcinoma
por: Kim, Bong Gap, et al.
Publicado: (2011)

The Oncologic Implications of Tumor Multiplicity in Intrahepatic Cholangiocarcinoma: Its Prognostic Value Might Be Underestimated
por: Yoon, So Jeong, et al.
Publicado: (2023)

Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Clinical and pathological significance of ROS1 expression in intrahepatic cholangiocarcinoma
por: Lee, Kyung-Hun, et al.
Publicado: (2015)

Proton Beam Therapy versus Photon Radiotherapy for Stage I Non-Small Cell Lung Cancer
por: Suh, Yang-Gun, et al.
Publicado: (2022)

Role of Acid and Weakly Acidic Reflux in Gastroesophageal Reflux Disease Off Proton Pump Inhibitor Therapy
por: Sung, Hea Jung, et al.
Publicado: (2012)

Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study
por: Park, Jongha, et al.
Publicado: (2009)

Integrative analysis of multiple genomic data from intrahepatic cholangiocarcinoma organoids enables tumor subtyping
por: Lee, Hee Seung, et al.
Publicado: (2023)

Intrahepatic cholangiocarcinoma arising in Caroli's disease
por: Jang, Min Hye, et al.
Publicado: (2014)

Prognostic factors predicting survival rate over 10 years of patients with intrahepatic cholangiocarcinoma after hepatic resection
por: Ma, Chung Hyeun, et al.
Publicado: (2020)

Risk of Pancreatic Cancer in Relation to ABO Blood Group and Hepatitis C Virus Infection in Korea: A Case-Control Study
por: Woo, Sang Myung, et al.
Publicado: (2013)

Characteristics of contrast-enhanced ultrasound in distinguishing small (≤3 cm) hepatocellular carcinoma from intrahepatic cholangiocarcinoma
por: Shin, Seung Kak, et al.
Publicado: (2018)

HPB PLENARY: OR-HPB-02: Endoscopic ultrasonography-guided intrahepatic portal vein embolization in an animal model
por: Park, Tae Young, et al.
Publicado: (2017)

Treatment outcomes of extended-field radiation therapy for thoracic superficial esophageal cancer
por: Lee, Doo Yeul, et al.
Publicado: (2017)

Factors for Predicting Favorable Outcome of Percutaneous Epidural Adhesiolysis for Lumbar Disc Herniation
por: Moon, Sang Ho, et al.
Publicado: (2017)

Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations
por: Kim, Young-Ho, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jksof5ukh8gul9qka86couo461